GGrantIndex
← Search

Senior Leaders

$570,294P30FY2010CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Linked publications, trials & patents

Paper 39713466Paper 39666914Paper 39605676Paper 39593217Paper 39536083Paper 39532885Paper 39484503Paper 39389170Paper 39322760Paper 39168126Paper 39160372Paper 39107288Paper 39042477Paper 39025073Paper 39024561Paper 38996877Paper 38992034Paper 38979326Paper 38979245Paper 38942046Paper 38924531Paper 38889153Paper 38861327Paper 38815709Trial NCT03029325Trial NCT02627430Trial NCT02142803Trial NCT02097225Trial NCT02079740Trial NCT01940809Trial NCT01835184Trial NCT01822509Trial NCT01575522Trial NCT01434316Trial NCT01307631Trial NCT01283035Trial NCT01116648Trial NCT01026324Trial NCT00956163Trial NCT00888134Trial NCT00662506Trial NCT00622401Trial NCT00458978Trial NCT00458549Trial NCT00429910Trial NCT00400946Trial NCT00376480Trial NCT00357500Trial NCT00301093Trial NCT00126672Trial NCT00101075Trial NCT00098865Trial NCT00098514Trial NCT00096291Trial NCT00095927Trial NCT00095901Trial NCT00095875Trial NCT00095836Trial NCT00090857Trial NCT00084838Trial NCT00083031Trial NCT00079326Trial NCT00072436Trial NCT00069940Trial NCT00053976Trial NCT00052611Trial NCT00047294Trial NCT00047281Trial NCT00020670Trial NCT00020605Trial NCT00007917Trial NCT00006107Trial NCT00005988Trial NCT00005096Trial NCT00004180Trial NCT00004163Trial NCT00004070Trial NCT00003761Trial NCT00003744Trial NCT00003657Trial NCT00003200Trial NCT00003058Trial NCT00003045Patent 9512485Patent 7786269Patent 7396678Patent 7229755Patent 7048929Patent 6908617Patent 6479284Patent 6479281Patent 5861424Patent 5670530Patent 5618831Patent 5502214Patent 5360803Patent 4625014Patent 4618492Patent 4542225Patent 4035566

Abstract

In addition to the Director and Deputy Director, the senior leadership of DF/HCC includes nine Associate Directors and thirteen Deputy Associate Directors (some of whom serve in more than one role). The Associate Directors have oversight and coordination responsibility for: Basic Science, Clinical Science, Population Science, Core Facilities, Planning and Evaluation, Development, Membership, and Administration. The Deputy Associate Director assists the respective Associate Director in his/her duties and is available to assume these duties should the Associate Director be unable to serve. These senior leaders meet every other week as the DF/HCC Executive Committee (EC), whose functions are described in Section 6.0 Organizational Capabilities. Six of these individuals also serve as Institutional Representatives. Dr. Fred Alt is the Institutional Representative for Children's Hospital Boston but does not currently serve as an Associate Director or Deputy Associate Director for the DF/HCC. Dr. Alt does participate as a member of the Executive Committee. Since the seven independent institutions participating in DF/HCC have different cultures as well as different locations, the primary responsibility of the Institutional Representative is for communication. In particular, they insure that the DF/HCC members within their institutions are aware of all activities, policies and procedures of the Cancer Center, and that the Center leadership is made aware of any issues from their institution. In addition, they are responsible for the day-to-day representation of the interests of DF/HCC at their institution, and the interests of their institution within DF/HCC. (Members of the Governance Committee have the ultimate responsibility for such institutional interests.)

View original record on NIH RePORTER →